Tech Company Financing Transactions

Rempex Pharmaceuticals Funding Round

Rempex Pharmaceuticals, based in Parsippany, secured $67.5 million in funding from Adams Street Partners, Frazier Healthcare Partners and OrbiMed.

Transaction Overview

Announced On
11/9/2011
Transaction Type
Venture Equity
Amount
$67,500,000
Round
Series B
Investors
Proceeds Purpose
This financing gives us the resources to rapidly advance our development programs towards commercialization at a time when the need for new treatments for resistant gram-negative infections has become critical.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
8 Sylvan Way
Parsippany, NJ 07054
USA
Overview
Rempex Pharmaceuticals, Inc. is a biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance.
Profile
Rempex Pharmaceuticals LinkedIn Company Profile
Social Media
Rempex Pharmaceuticals Company Twitter Account
Company News
Rempex Pharmaceuticals News
Facebook
Rempex Pharmaceuticals on Facebook
YouTube
Rempex Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Daniel Burgess
  Daniel Burgess LinkedIn Profile  Daniel Burgess Twitter Account  Daniel Burgess News  Daniel Burgess on Facebook
Chief Financial Officer
Eric Loumeau
  Eric Loumeau LinkedIn Profile  Eric Loumeau Twitter Account  Eric Loumeau News  Eric Loumeau on Facebook
Chief Medical Officer
Jeffery Loutit
  Jeffery Loutit LinkedIn Profile  Jeffery Loutit Twitter Account  Jeffery Loutit News  Jeffery Loutit on Facebook
Chief Operating Officer
Jennifer Cayer
  Jennifer Cayer LinkedIn Profile  Jennifer Cayer Twitter Account  Jennifer Cayer News  Jennifer Cayer on Facebook
Chief Scientific Officer
Michael Dudley
  Michael Dudley LinkedIn Profile  Michael Dudley Twitter Account  Michael Dudley News  Michael Dudley on Facebook
VP - Operations
Elizabeth Morgan
  Elizabeth Morgan LinkedIn Profile  Elizabeth Morgan Twitter Account  Elizabeth Morgan News  Elizabeth Morgan on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/9/2011: Flowdock venture capital transaction
Next: 11/9/2011: Medialets venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary